192 related articles for article (PubMed ID: 31706270)
1. Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data.
Constantin J; Atanasov P; Wirth D; Borsi A
BMC Gastroenterol; 2019 Nov; 19(1):179. PubMed ID: 31706270
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
[TBL] [Abstract][Full Text] [Related]
4. Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
Aldeguer X; Sicras-Mainar A
Gastroenterol Hepatol; 2016 Jan; 39(1):9-19. PubMed ID: 26211705
[TBL] [Abstract][Full Text] [Related]
5. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis.
Cichewicz A; Tencer T; Gupte-Singh K; Egodage S; Burnett H; Kumar J
Adv Ther; 2023 May; 40(5):2116-2146. PubMed ID: 37000363
[TBL] [Abstract][Full Text] [Related]
7. Indirect health costs in ulcerative colitis and Crohn's disease: a systematic review and meta-analysis.
Kawalec P; Malinowski KP
Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):253-66. PubMed ID: 25656310
[TBL] [Abstract][Full Text] [Related]
8. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
[TBL] [Abstract][Full Text] [Related]
9. Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.
Pilon D; Ding Z; Muser E; Obando C; Voelker J; Manceur AM; Kinkead F; Lafeuille MH; Lefebvre P
Curr Med Res Opin; 2020 Aug; 36(8):1285-1294. PubMed ID: 32427006
[No Abstract] [Full Text] [Related]
10. The direct and indirect costs associated with endometriosis: a systematic literature review.
Soliman AM; Yang H; Du EX; Kelley C; Winkel C
Hum Reprod; 2016 Apr; 31(4):712-22. PubMed ID: 26851604
[TBL] [Abstract][Full Text] [Related]
11. Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review.
Kawalec P
Arch Med Sci; 2016 Apr; 12(2):295-302. PubMed ID: 27186172
[TBL] [Abstract][Full Text] [Related]
12. Sick leave and disability pension in inflammatory bowel disease: a systematic review.
Büsch K; da Silva SA; Holton M; Rabacow FM; Khalili H; Ludvigsson JF
J Crohns Colitis; 2014 Nov; 8(11):1362-77. PubMed ID: 25001582
[TBL] [Abstract][Full Text] [Related]
13. Systematic review: the costs of ulcerative colitis in Western countries.
Cohen RD; Yu AP; Wu EQ; Xie J; Mulani PM; Chao J
Aliment Pharmacol Ther; 2010 Apr; 31(7):693-707. PubMed ID: 20064142
[TBL] [Abstract][Full Text] [Related]
14. Relationship between physician-based assessment of disease activity, quality of life, and costs of ulcerative colitis in Poland.
Kawalec P; Stawowczyk E
Prz Gastroenterol; 2018; 13(1):61-68. PubMed ID: 29657613
[TBL] [Abstract][Full Text] [Related]
15. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States.
Ding Z; Muser E; Izanec J; Lukanova R; Kershaw J; Roughley A
Crohns Colitis 360; 2022 Jul; 4(3):otac023. PubMed ID: 36777416
[TBL] [Abstract][Full Text] [Related]
16. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
Holko P; Kawalec P; Mossakowska M; Pilc A
PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
[TBL] [Abstract][Full Text] [Related]
17. Systematic review: the financial burden of surgical complications in patients with ulcerative colitis.
Lindsay JO; Bergman A; Patel AS; Alesso SM; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2015 Jun; 41(11):1066-78. PubMed ID: 25855078
[TBL] [Abstract][Full Text] [Related]
18. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
19. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
Robinson LS; Sarkies M; Brown T; O'Brien L
Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis.
Stawowczyk E; Kawalec P
Pharmacoeconomics; 2018 Apr; 36(4):419-434. PubMed ID: 29260508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
